Literature DB >> 9228035

Mitosis-specific negative regulation of epidermal growth factor receptor, triggered by a decrease in ligand binding and dimerization, can be overcome by overexpression of receptor.

N Kiyokawa1, E K Lee, D Karunagaran, S Y Lin, M C Hung.   

Abstract

The function of epidermal growth factor receptor (EGFR) was found to be negatively regulated in M phase in which it showed less phosphotyrosine content and reduced intrinsic kinase activity accompanied by retarded electrophoretic mobility owing to total hyperphosphorylation. Ligand-induced autophosphorylation and downstream signaling of EGFR were tightly suppressed in M phase due to a decrease in ligand binding affinity and the inability of epidermal growth factor (EGF) to induce receptor dimerization. There was no change in the number of surface-exposed EGF receptors between G0/G1 and M phases of the cell cycle. Hyperphosphorylation (due to serine and/or threonine phosphorylation) correlates with the unresponsiveness of cells to EGF-mediated stimulation of tyrosine phosphorylation in cells that express the normal or basal level of EGFR. This M phase-specific negative regulation was overcome by overexpression of EGFR, which was responsive to ligand throughout the cell cycle and revealed ligand-induced signaling in the M phase. These findings indicate that EGFR does not respond to ligand stimulation in M phase and suggest that a negative regulation of ligand-receptor interactions in M phase may control the normal function of receptor tyrosine kinase and that receptor overexpression will disrupt this cell cycle-dependent regulation of receptor tyrosine kinases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9228035     DOI: 10.1074/jbc.272.30.18656

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Controlling tumor-derived and vascular endothelial cell growth: role of the 4Ff2 cell surface antigen.

Authors:  M Papetti; I M Herman
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

2.  Effects of insulin-like growth factor-1 on B-cell precursor acute lymphoblastic leukemia.

Authors:  Hiroyuki Yamada; Kazutoshi Iijima; Osamu Tomita; Tomoko Taguchi; Masashi Miharu; Kenichiro Kobayashi; Hajime Okita; Masahiro Saito; Toshiaki Shimizu; Nobutaka Kiyokawa
Journal:  Int J Hematol       Date:  2012-12-19       Impact factor: 2.490

3.  Differential effects of BAFF on B cell precursor acute lymphoblastic leukemia and Burkitt lymphoma.

Authors:  Keiko Onda; Kazutoshi Iijima; Yohko U Katagiri; Hajime Okita; Masahiro Saito; Toshiaki Shimizu; Nobutaka Kiyokawa
Journal:  Int J Hematol       Date:  2010-04-29       Impact factor: 2.490

4.  Combination of chemical genetics and phosphoproteomics for kinase signaling analysis enables confident identification of cellular downstream targets.

Authors:  Felix S Oppermann; Kathrin Grundner-Culemann; Chanchal Kumar; Oliver J Gruss; Prasad V Jallepalli; Henrik Daub
Journal:  Mol Cell Proteomics       Date:  2011-12-22       Impact factor: 5.911

5.  Extracellular signal-regulated kinase 1/2 activity is not required in mammalian cells during late G2 for timely entry into or exit from mitosis.

Authors:  Mio Shinohara; Alexei V Mikhailov; Julio A Aguirre-Ghiso; Conly L Rieder
Journal:  Mol Biol Cell       Date:  2006-10-11       Impact factor: 4.138

6.  Membrane-bound trafficking regulates nuclear transport of integral epidermal growth factor receptor (EGFR) and ErbB-2.

Authors:  Ying-Nai Wang; Heng-Huan Lee; Hong-Jen Lee; Yi Du; Hirohito Yamaguchi; Mien-Chie Hung
Journal:  J Biol Chem       Date:  2012-03-28       Impact factor: 5.157

7.  Deficiency of BLNK hampers PLC-gamma2 phosphorylation and Ca2+ influx induced by the pre-B-cell receptor in human pre-B cells.

Authors:  Tomoko Taguchi; Nobutaka Kiyokawa; Hisami Takenouch; Jun Matsui; Wei-Ran Tang; Hideki Nakajima; Kyoko Suzuki; Yusuke Shiozawa; Masahiro Saito; Yohko U Katagiri; Takao Takahashi; Hajime Karasuyama; Yoshinobu Matsuo; Hajime Okita; Junichiro Fujimoto
Journal:  Immunology       Date:  2004-08       Impact factor: 7.397

8.  B-cell-activating factor inhibits CD20-mediated and B-cell receptor-mediated apoptosis in human B cells.

Authors:  Yohei Saito; Yoshitaka Miyagawa; Keiko Onda; Hideki Nakajima; Ban Sato; Yasuomi Horiuchi; Hajime Okita; Yohko U Katagiri; Masahiro Saito; Toshiaki Shimizu; Junichiro Fujimoto; Nobutaka Kiyokawa
Journal:  Immunology       Date:  2008-06-06       Impact factor: 7.397

9.  Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression.

Authors:  Hui-Wen Lo; Sheng-Chieh Hsu; Weiya Xia; Xinyu Cao; Jin-Yuan Shih; Yongkun Wei; James L Abbruzzese; Gabriel N Hortobagyi; Mien-Chie Hung
Journal:  Cancer Res       Date:  2007-10-01       Impact factor: 12.701

10.  Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice.

Authors:  Laura N Burga; Hai Hu; Ashish Juvekar; Nadine M Tung; Susan L Troyan; Erin W Hofstatter; Gerburg M Wulf
Journal:  Breast Cancer Res       Date:  2011-03-11       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.